Firms
Theme

HWKN

Hawkins Inc · NASDAQ

News

3 latest

Zacks Investment Research

AXTA vs. HWKN: Which Stock Should Value Investors Buy Now?

A comparison of two chemical-specialty sector stocks reveals that Axalta Coating Systems (AXTA) presents a better value opportunity than Hawkins (HWKN). AXTA has a Zacks Rank of #2 (Buy) with a Value grade of B, supported by a lower forward P/E ratio of 12.61 and PEG ratio of 1.53. In contrast, HWKN carries a Zacks Rank of #4 (Sell) with a Value grade of D, featuring a higher forward P/E of 32.18 and PEG ratio of 2.68, making it less attractive to value investors.

Zacks Investment Research

Hawkins Expands Texas Water Treatment With Eagle Labs Buyout

Hawkins, Inc. (HWKN) has completed its acquisition of Eagle Labs, Inc., expanding its Water Treatment business into the Dallas-Fort Worth region of Texas. The acquisition adds two locations and brings HWKN's total Texas Water Treatment facilities to seven.

Zacks Investment Research

AXTA or HWKN: Which Is the Better Value Stock Right Now?

In a comparison of two Chemical - Specialty stocks, Axalta Coating Systems (AXTA) emerges as the more attractive option for value investors. AXTA holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 12.42 and PEG ratio of 1.51. Hawkins (HWKN) has a Zacks Rank #4 (Sell) with a Value grade of D, showing a forward P/E of 31.38 and PEG ratio of 2.62, indicating it is relatively overvalued.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $HWKN · 0 threads

Sign in to post on $HWKN

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev